Clinical trial
An Open-Label Extension Study to Assess the Long-term Safety and Efficacy of Mipomersen in Subjects With Familial Hypercholesterolemia
NCT00477594 is registered in ClinicalTrials.gov with Kastle Therapeutics, LLC as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Open-Label Extension Study to Assess the Long-term Safety and Efficacy of Mipomersen in Subjects With Familial Hypercholesterolemia
- Lead sponsor
- Kastle Therapeutics, LLC
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- May 31, 2007
- Completion date
- July 31, 2011
- Enrollment
- 21 (actual)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.
congenital abnormalities, dyslipidemias, genetic diseases, inborn, hypercholesterolemia, hypercholesterolemia, autosomal dominant, hyperlipidemias, hyperlipoproteinemia type ii, hyperlipoproteinemias, infant, newborn, diseases, lipid metabolism disorders, lipid metabolism, inborn errors, metabolic diseases, metabolic disorder, metabolism, inborn errors